Brief: Junshi Biosciences' Prelim 2024 Net Loss At 1.3 Billion Yuan
Feb 27 (Reuters) - Shanghai Junshi Biosciences Co Ltd 688180.SS: PRELIM 2024 NET LOSS AT 1.3 BILLION YUAN ($178.80 million) Source text Further company coverage: 688180.SS ($1 = 7.2708 Chinese yuan renminbi) (Reporting by Beijing Newsroom) ((Ethan.Wang@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab